— Know what they know.
Not Investment Advice

CHMA NASDAQ

Chiasma, Inc.
1W: -9.4% 1M: -14.0% 3M: -5.5% 1Y: -20.5% 3Y: +168.6% 5Y: +38.2%
$3.76
Last traded 2021-08-05 — delisted
NASDAQ · Healthcare · Biotechnology

Income Trends

Revenue
$1M +0.0% ▲
Gross Profit
$1M +0.0% ▲
Operating Income
-$71M -88.0% ▼
Net Income
-$75M -105.9% ▼
EPS (Diluted)
$-1.43 -34.9% ▼
EBITDA
-$69M -92.6% ▼

Profit Margins

Year-over-Year Growth

View Full Income Statement
Line ItemFY2016FY2017FY2018FY2019FY2020
Revenue$0$0$0$0$1M
YoY Growth+0.0%+0.0%+0.0%+0.0%+0.0%
Cost of Revenue$0$0$0$0$61K
Gross Profit$0$0$0$0$1M
Gross Margin————94.5%
R&D Expenses$31M$18M$22M$22M$27M
SG&A Expenses$22M$9M$10M$15M$45M
Operating Expenses$53M$27M$32M$38M$72M
Operating Income-$61M-$28M-$32M-$38M-$71M
Operating Margin————-6387.8%
Interest Expense$264K$131K$6K$19K$6M
Income Before Tax-$61M-$27M-$31M-$36M-$75M
Tax Expense$347K-$590K-$31K$284K$84K
Net Income-$61M-$27M-$31M-$36M-$75M
Net Margin————-6761.2%
EPS (Diluted)$-2.51$-1.10$-1.28$-1.06$-1.43
EBITDA-$60M-$27M-$31M-$36M-$69M
Shares Outstanding24M24M24M34M52M

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms